Bulletin
Investor Alert

London Markets Open in:

Biogen Inc.

NAS: BIIB

GO
/marketstate/country/us

After Hours

/zigman2/quotes/201531540/composite

$

306.50

Change

+1.33 +0.44%

Volume

Volume 314,107

Nov 30, 2022, 7:55 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/201531540/composite

Previous close

$ 291.41

$ 305.17

Change

+13.76 +4.72%

Day low

Day high

$301.20

$311.88

Open
Open: 306.28

52 week low

52 week high

$187.16

$311.88

Open

Market cap

$41.96B

Average volume

1.88M

P/E ratio

15.55

Rev. per Employee

$1.00M

EPS

19.63

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/biib

MarketWatch News on BIIB

  1. Big News for Biogen Landed Tuesday. The Company Didn't Get a Mention.

    10:32 a.m. Nov. 30, 2022

    - Josh Nathan-Kazis

  2. Biogen stock up 3% premarket after update on Alzheimer's disease treatment

    6:40 a.m. Nov. 30, 2022

    - Ciara Linnane

  3. Biogen, Eisai's Alzheimer's Data Confirm Benefit but Questions Loom

    5:04 a.m. Nov. 30, 2022

    - Josh Nathan-Kazis

  4. Biogen's New Alzheimer's Drug Faces Its Next Test. 5 Big Questions.

    11:29 a.m. Nov. 28, 2022

    - Josh Nathan-Kazis

  5. Teva names former Sandoz chief Richard Francis as new CEO

    7:16 a.m. Nov. 21, 2022

    - Steve Gelsi

  6. Biogen stock price target raised to $350 from $265 at Truist

    7:28 a.m. Nov. 15, 2022

    - Tomi Kilgore

  7. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/biib

Other News on BIIB

  1. New Alzheimer’s Drug Shows Positive Results but Side Effects

    7:50 p.m. Nov. 29, 2022

    - Joseph Walker

  2. Steven Cohen Loads Up on Workday, Dumps Coca-Cola

    5:26 p.m. Nov. 29, 2022

    - GuruFocus.com

  3. Biogen (BIIB) Down on Report of Death in Alzheimer's Study

    12:42 p.m. Nov. 29, 2022

    - Zacks.com

  4. BIIB or RGEN: Which Is the Better Value Stock Right Now?

    11:40 a.m. Nov. 23, 2022

    - Zacks.com

  5. Regeneron's (REGN) Libtayo Gets EC Nod for Cervical Cancer

    10:41 a.m. Nov. 23, 2022

    - Zacks.com

  6. Teva Pharmaceutical Names Richard Francis as CEO

    10:13 a.m. Nov. 21, 2022

    - Colin Kellaher

  7. Retirement Systems of Alabama Buys 2, Sells 3 in 3rd Quarter

    12:00 p.m. Nov. 17, 2022

    - GuruFocus.com

  8. Is Biogen (BIIB) a Great Value Stock Right Now?

    9:40 a.m. Nov. 17, 2022

    - Zacks.com

  9. Loading more headlines...
/news/pressrelease/company/us/biib

Press Releases on BIIB

  1. S&P 500 Movers: TECH, STT

    10:43 a.m. Nov. 30, 2022

    - MarketNewsVideo.com

  2. Biogen Climbs After Alzheimer Drug Tests

    10:27 a.m. Nov. 30, 2022

    - Baystreet.ca

  3. When Biogen Inc. Common Stock (BIIB) Moves Investors should Listen

    2:17 a.m. Nov. 30, 2022

    - Stock Traders Daily

  4. Nasdaq 100 Movers: BIIB, PDD

    11:36 a.m. Nov. 28, 2022

    - MarketNewsVideo.com

  5. Learn to Evaluate Biogen Inc. Common Stock (BIIB) using the Charts

    12:13 p.m. Nov. 20, 2022

    - Stock Traders Daily

  6. Nasdaq 100 Movers: TEAM, BIIB

    10:51 a.m. Nov. 14, 2022

    - MarketNewsVideo.com

  7. S&P 500 Movers: HAS, MRNA

    10:48 a.m. Nov. 14, 2022

    - MarketNewsVideo.com

  8. Biogen Inc. Common Stock BIIB Technical Data

    7:14 p.m. Nov. 10, 2022

    - Stock Traders Daily

  9. Loading more headlines...

Rates »

Link to MarketWatch's Slice.